New Blood, circa 1914

World War I provided testing grounds for novel blood-transfusion techniques.

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

LET IT FLOW: After researchers discovered that sodium citrate could prevent the coagulation of blood for many hours—some claimed for as long as 48 hours, though transfusions were typically performed on the same day as the blood extraction—doctors would put a small amount of the substance in a glass flask and add blood collected directly from the arm of a donor. The blood was then transfused into a patient from the flask. This image was published in a review of the technique by one of its many pioneers, Richard Lewisohn, a surgeon at Mount Sinai Hospital in New York, who helped identify the appropriate dosage of sodium citrate that would keep the blood liquid without being toxic to the recipient. THE BOSTON MEDICAL AND SURGICAL JOURNAL, 190:733-42, 1924.In a dramatic and widely publicized feat in 1908, French surgeon Alexis Carrel, working at the Rockefeller Institute for Medical Research in New York City, demonstrated the relatively new technique of direct blood transfusion. To save a baby’s life, he connected the artery of a surgeon’s arm with a vein in the leg of the surgeon’s infant daughter. The method, which he and others had been developing for the past couple of years, circumvented the problem of coagulation that had long challenged blood transfusion efforts. As soon as blood is exposed to air, it begins to coagulate; directly connecting the vessels of donor and recipient avoided contact with air altogether.

“Blood could actually flow from individual to individual and really bring people back from death itself,” says Susan Lederer, a professor of medical history and bioethics at the University of Wisconsin School of Medicine and Public Health.

But the technique required great skill, limiting its implementation to only the most accomplished surgeons, such as transfusion pioneer George Washington Crile, who was one of the first to adapt Carrel’s techniques at the St. Alexis Hospital in Cleveland. Among transfusion practitioners, there was a push to discover a compound that could prevent coagulation enough to support indirect transfusion, without causing excessive bleeding or introducing toxins to the blood.

Various compounds in solution were already used for other anticlotting purposes. Jewish butchers, for instance, used salt solutions to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies